0.10Open0.10Pre Close2 Volume148 Open Interest0.50Strike Price20.00Turnover456.80%IV11.11%PremiumJul 19, 2024Expiry Date0.05Intrinsic Value100Multiplier2DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.5309Delta2.2893Gamma6.00Leverage Ratio-0.0147Theta0.0000Rho-3.19Eff Leverage0.0002Vega
Sangamo Therapeutics Stock Discussion
Sangamo Therapeutics recently presented critical pre-clinical data on its innovative next-generation integrase technology, the Modular Integrase (MINT) platform, highlighting a significant advancement in the field of genome editing. The announcement came as part of their participation at the 27th Amer...
No comment yet